CHILDRENS IBUPROFEN ORAL SUSPENSION
Generic: IBUPROFEN
PAI HoldingsManufacturer
ORALRoute
IBUPROFENActive Substance
2024-11-08Original Approval
CHILDRENS IBUPROFEN ORAL SUSPENSION is FDA application ANDA214789, sponsored by PAI HOLDINGS PHARM. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
15,930 reports
2
PAIN
15,216 reports
3
FATIGUE
14,694 reports
4
NAUSEA
13,725 reports
5
HEADACHE
12,241 reports
6
ARTHRALGIA
11,062 reports
7
DYSPNOEA
10,659 reports
8
VOMITING
10,121 reports
9
DIARRHOEA
9,835 reports
10
RASH
9,143 reports